Ravi Gundadka Shriram (Ravi G S)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Hyaluronic Acid

Clinical Evaluation

Top Venues

Expert opinion on drug safety

Turkish journal of pharmaceutical sciences

Pharmaceuticals (Basel, Switzerland)

Therapeutic advances in drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Ravi Gundadka Shriram, Afrasim Moin, Hadil Faris Alotaibi, El-Sayed Khafagy, Ahmed Al Saqr, Amr Selim Abu Lila, Rompicherla Narayana Charyulu
Phytosomes as a Plausible Nano-Delivery System for Enhanced Oral Bioavailability and Improved Hepatoprotective Activity of Silymarin. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)
Sandeep Divate Sathyanarayana, Swapnil Dylan Fernandes, Lovely Joylen Castelino, Anoop Narayanan Vadakkepushpakath, Ravi Gundadka Shriram
Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges. Clinical and experimental vaccine research 9 (2) (2020)
Sumedha Prashanth Payyal, Rompicherla Narayana Charyulu, Sandeep Divate Sathyanarayana, Ravi Gundadka Shriram, Anoop Narayanan Vadakkepushpakath
Microemulsion Based Gel of Sulconazole Nitrate for Topical Application. Turkish journal of pharmaceutical sciences 17 (3) (2020)
Nikhil Raj, Swapnil Fernandes, Narayana R Charyulu, Akhilesh Dubey, Ravi Gundadka Shriram, Srinivas Hebbar
Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada. Therapeutic advances in drug safety 10 (2019)
Marlon Ramcy Henry Miranda, Akhilesh Dubey, Ravi Gundadka Shriram, R Narayana Charyulu
Fixed-dose combinations banned in India: is it the right decision? An eye-opening review. Expert opinion on drug safety 18 (10) (2019)